
Bayer reports positive data from Phase III ARAMIS trial
Bayer has reported positive results from its Phase III ARAMIS trial after it met the primary endpoint.
Bayer has reported positive results from its Phase III ARAMIS trial after it met the primary endpoint.
Thank you for subscribing to Clinical Trials Arena